MabVax Therapeutics Raises $3 Million In Common Stock Financing And An …
On July 7th, investors in the Series C Preferred Stock financing that closed in February of this year exercised warrants to purchase additional shares of MabVax Series C Preferred Stock. Total proceeds from the exercise of the C-1 warrants were $1.5 …
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.